Ursula von der Leyen has been criticized by cross-party MEPs over the trade deal with Donald Trump, which excludes pharmaceuticals from tariffs but allows a 15% cap. Many voices in the European People's Party (EPP) and other political groups believe the deal favors the US and weakens the European Union's position. Additional critics are calling for transparency and publication of the details of the deal, pointing out that while economically it is an improvement, it is a political defeat for the EU.
Sources
Eurodeputaţii o acuză pe Ursula von der Leyen că și-a depășit mandatul și a cedat în faţa intereselor americane
Eurodeputații critică acordul negociat de către Ursula von der Leyen cu Donald Trump: „Ambele părţi trebuie să câştige ceva”
'O zi sumbră pentru Europa'. Franța critică acordul comercial dintre UE și SUA
UE: „Nu am luat încă nicio decizie cu privire la web tax”
Latest News
10:05
Post-Brexit reset: the EU and the United Kingdom close to a historic agreement on youth mobility and trade
09:56
Data belonging to JPMorgan, Visa, and Mastercard customers was stolen in a cyberattack on a vendor
09:47
DSU: Wind caused damage in 81 localities in 24 counties and in Bucharest / No casualties, isolated persons, or medical emergencies blocked due to the weather were reported
09:34
November 2026: Informat.ro – INSCOP Research BAROMETER, 15th Edition – Chapter XI: Surveillance Cameras
09:29
GTA VI reportedly generated $2.36 billion on its first day of release
See more news